MeCP2 involvement in the regulation of neuronal α-tubulin production

Human Molecular Genetics

Volumn 18, Issue 8, 2009, Pages 1415-1423

  Abuhatzira, Liron ^a   Shemer, Ruth ^a   Razin, Aharon ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CYTOSKELETON PROTEIN; METHYL CPG BINDING PROTEIN 2;

ADULT; ARTICLE; AUTISM; BRAIN TISSUE; CASE REPORT; CHILD; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; GENE EXPRESSION REGULATION; HAPPY PUPPET SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; RETT SYNDROME;

ADULT; AGED, 80 AND OVER; ANIMALS; AUTISTIC DISORDER; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSKELETON; FEMALE; FIBROBLASTS; HUMANS; INFANT; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; RETT SYNDROME; TUBULIN;

EID: 64549113411     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp048     Document Type: Article

References (45)

1. Balmer, D., Goldstine, J., Rao, Y.M. and LaSalle, J.M. (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med., 81, 61-68.
2. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell- specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
3. Akbarian, S., Chen, R.Z., Gribnau, J., Rasmussen, T.P., Fong, H., Jaenisch, R. and Jones, E.G. (2001) Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis., 8, 784-791.
4. Jones, P.L., Veenstra, G.J.C., Wade, P.A., Vermaak, D., Kass, S.U., Landsberg, N., Strouboulis, J. and Wolffe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
5. Nan, X., Ng, H.-H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
6. Harikrishnan, K.N., Chow, M.Z., Baker, E.K., Pal, S., Bassal, S., Brasacchio, D., Wang, L., Craig, J.M., Jones, P.L., Sif, S. et al. (2005) Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet., 37, 254-264.
7. Nan, X., Campoy, F.J. and Bird, A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
8. Hendrich, B. and Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538-6547.
9. Razin, A. (1998) CpG methylation, chromatin structure and gene silencing - a three-way connection. EMBO J., 17, 4905-4908.
10. Abuhatzira, L., Makedonski, K., Kaufman, Y., Razin, A. and Shemer, R. (2007) MeCP2 deficiency in the brain decreases BDNF levels by REST/ CoREST-mediated repression and increases TRKB production. Epigenetics 2, 214-222.
11. Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., Thatcher, K.N., Farnham, P.J. and Lasalle, J.M. (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104, 19416-19421.
12. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J. and Zoghbi, H.Y. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320, 1224-1229.
13. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23 185-188.
14. Sirianni, N., Naidu, S., Pereira, J., Pillotto, R.F. and Hoffman, E.P. (1998) Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am. J. Hum. Genet., 63, 1552-1558.
15. Ellaway, C. and Christodoulou, J. (1999) Rett syndrome: Clinical update and review of recent genetic advances. J. Paediatr. Child Health, 35, 419-426.
16. Van den Veyver, I.B. and Zoghbi, H.Y. (2000) Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr. Opin. Genet. Dev., 10, 275-279.
17. Kaufmann, W.E., Taylor, C.V., Hohmann, C.F., Sanwal, I.B. and Naidu, S. (1997) Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. Eur. Child. Adolesc. Psychiatry, 6(Suppl. 1), 75-77.
18. Armstrong, D.D., Dunn, K. and Antalffy, B. (1998) Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol., 57, 1013-1017.
19. Barinaga, M. (1995) Dendrites shed their dull image. Science, 268, 200-201.
20. Kaech, S., Ludin, B. and Matus, A. (1996) Cytoskeletal plasticity in cells expressing neuronal microtubule-associated proteins. Neuron, 17, 1189-1199.
21. Azmitia, E.C. (2001) Neuronal instability: Implications for Rett's syndrome. Brain Dev., 23 (Suppl. 1), S1-S10.
22. Kunze, D. and Rustow, B. (1993) Pathobiochemical aspects of cytoskeleton components. Eur. J. Clin. Chem. Clin. Biochem., 31, 477-489.
23. Clayton-Smith, J. and Laan, L. (2003) Angelman syndrome: A review of the clinical and genetic aspects. J. Med. Genet., 40, 87-95.
24. Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B. and Clayton-Smith, J. (2001) Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet., 38, 224-228.
25. Imessaoudene, B., Bonnefont, J.P., Royer, G., Cormier-Daire, V., Lyonnet, S., Lyon, G., Munnich, A. and Amiel, J. (2001) MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J. Med. Genet., 38, 171-174.
26. Hitchins, M.P., Rickard, S., Dhalla, F., de Vries, B.B., Winter, R., Pembrey, M.E. and Malcolm, S. (2004) Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am. J. Med. Genet., 125A, 167-172.
27. Williams, C.A. (2005) Neurological aspects of the Angelman syndrome. Brain Dev., 27, 88-94.
28. Nagarajan, R.P., Hogart, A.R., Gwye, Y., Martin, M.R. and LaSalle, J.M. (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics, 1, e1-e11.
29. Makedonski, K., Abuhatzira, L., Razin, A. and Shemer, R. (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affect UBE3A expression. Hum. Mol. Genet., 14, 1049-1058.
30. Samaco, R.C., Hogart, A. and LaSalle, J.M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet., 14 483-492.
31. Dindot, S.V., Antalffy, B.A., Bhattacharjee, M.B. and Beaudet, A.L. (2008) The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet., 17, 111-118.
32. Westermann, S. and Weber, K. (2003) Post-translational modifications regulate microtubule function. Nat. Rev. Mol. Cell. Biol., 4 938-947.
33. Barra, H.S., Arce, C.A. and Argarana, C.E. (1988) Posttranslational tyrosination/detyrosination of tubulin. Mol. Neurobiol., 2, 133-153.
34. Ersfeld, K., Wehland, J., Plessmann, U., Dodemont, H., Gerke, V. and Weber, K. (1993) Characterization of the tubulin-tyrosine ligase. J. Cell. Biol., 120, 725-732.
35. Webster, D.R., Wehland, J., Weber, K. and Borisy, G.G. (1990) Detyrosination of alpha tubulin does not stabilize microtubules in vivo. J. Cell. Biol., 111, 113-122.
36. Baas, P.W. and Black, M.M. (1990) Individual microtubules in the axon consist of domains that differ in both composition and stability. J. Cell. Biol., 111, 495-509.
37. Paturle-Lafanechere, L., Edde, B., Denoulet, P., Van Dorsselaer, A., Mazarguil, H., Le Caer, J.P., Wehland, J. and Job, D. (1991) Characterization of a major brain tubulin variant which cannot be tyrosinated. Biochemistry, 30, 10523-10528.
38. Paturle-Lafanechere, L., Manier, M., Trigault, N., Pirollet, F., Mazarguil, H. and Job, D. (1994) Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies. J. Cell. Sci., 107, 1529-1543.
39. Bruce, A.W., Donaldson, I.J., Wood, I.C., Yerbury, S.A., Sadowski, M.I., Chapman, M., Gottgens, B. and Buckley, N.J. (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc. Natl Acad. Sci. USA 101, 10458-10463.
40. Preston, S.F., Deanin, G.G., Hanson, R.K. and Gordon, M.W. (1979) The phylogenetic distribution of tubulin:tYrosine ligase. J.Mol. Evol. 13, 233-244.
41. Liao, G. and Gundersen, G.G. (1998) Kinesin is a candidate for cross-bridging microtubules and intermediate filaments. Selective binding of kinesin to detyrosinated tubulin and vimentin. J. Biol. Chem., 273, 9797-9803.
42. Kreitzer, G., Liao, G. and Gundersen, G.G. (1999) Detyrosination of tubulin regulates the interaction of intermediate filaments with microtubules in vivo via a kinesin-dependent mechanism. Mol. Biol. Cell., 10, 1105-1118.
43. Lin, S.X., Gundersen, G.G. and Maxfield, F.R. (2002) Export from pericentriolar endocytic recycling compartment to cell surface depends on stable, detyrosinated (glu) microtubules and kinesin. Mol. Biol. Cell., 13, 96-109.
44. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147.
45. Huttenlocher, P.R. and Dabholkar, A.S. (1997) Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol., 387 167-178.